CVE-2022-32285

Description

A vulnerability has been identified in Mendix SAML Module (Mendix 7 compatible) (All versions < V1.16.6), Mendix SAML Module (Mendix 8 compatible) (All versions < V2.2.2), Mendix SAML Module (Mendix 9 compatible) (All versions < V3.2.3). The affected module is vulnerable to XML External Entity (XXE) attacks due to insufficient input sanitation. This may allow an attacker to disclose confidential data under certain circumstances.

Category

7.5
CVSS
Severity: High
CVSS 3.1 •
CVSS 2.0 •
EPSS 0.12%
Third-Party Advisory siemens.com
Affected: Siemens Mendix SAML Module (Mendix 7 compatible)
Affected: Siemens Mendix SAML Module (Mendix 8 compatible)
Affected: Siemens Mendix SAML Module (Mendix 9 compatible)
Published at:
Updated at:

References

Frequently Asked Questions

What is the severity of CVE-2022-32285?
CVE-2022-32285 has been scored as a high severity vulnerability.
How to fix CVE-2022-32285?
To fix CVE-2022-32285, make sure you are using an up-to-date version of the affected component(s) by checking the vendor release notes. As for now, there are no other specific guidelines available.
Is CVE-2022-32285 being actively exploited in the wild?
As for now, there are no information to confirm that CVE-2022-32285 is being actively exploited. According to its EPSS score, there is a ~0% probability that this vulnerability will be exploited by malicious actors in the next 30 days.
What software or system is affected by CVE-2022-32285?
CVE-2022-32285 affects Siemens Mendix SAML Module (Mendix 7 compatible), Siemens Mendix SAML Module (Mendix 8 compatible), Siemens Mendix SAML Module (Mendix 9 compatible).
This platform uses data from the NIST NVD, MITRE CVE, MITRE CWE, First.org and CISA KEV but is not endorsed or certified by these entities. CVE is a registred trademark of the MITRE Corporation and the authoritative source of CVE content is MITRE's CVE web site. CWE is a registred trademark of the MITRE Corporation and the authoritative source of CWE content is MITRE's CWE web site.
© 2025 Under My Watch. All Rights Reserved.